In addition, Globus Medical has granted the underwriters a 30-day option to purchase up to an additional 1.25 million shares of common stock to cover any over-allotments. Closing of the offering is expected to occur on Aug. 8, subject to customary closing conditions. The shares are expected to begin trading on the New York Stock Exchange today under the symbol GMED.
More Articles on Orthopedic Devices:
Global Spinal Devices and Biologics Market to Grow 6.9% Annually
DePuy Synthes Spine Systems Receive FDA Approval to Treat Scoliosis
Symmetry Medical Announces 2Q Revenue of $102.3M, 8% Increase
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
